€24.30
2.10% today
L&S, Jul 02, 10:05 pm CET
ISIN
US68213N1090
Symbol
OMCL
Sector
Industry

Omnicell, Inc. Share price

$26.65
-4.96 15.69% 1M
-10.98 29.18% 6M
-10.98 29.18% YTD
-46.31 63.47% 1Y
-122.04 82.08% 3Y
-61.69 69.83% 5Y
-2.72 9.26% 10Y
Nasdaq, Closing price Mon, Jul 01 2024
-0.42 1.55%
ISIN
US68213N1090
Symbol
OMCL
Sector
Industry

Key metrics

Market capitalization $1.22b
Enterprise Value $1.29b
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 7.24
EV/Sales (TTM) EV/Sales 1.17
P/S ratio (TTM) P/S ratio 1.11
P/B ratio (TTM) P/B ratio 1.03
Sales growth (TTM) Sales growth -13.02%
Turnover (TTM) Turnover $1.10b
EBIT (operating result TTM) EBIT $-20.38m
Free cash flow (TTM) Free cash flow $177.99m
Cash position $549.96m
EPS (TTM) EPS $-0.46
P/E ratio expected negative
P/S ratio expected 1.14
EV/Sales expected 1.21
Short interest 6.16%
Show more

Is Omnicell, Inc. a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,954 shares worldwide.

Omnicell, Inc. Share analysis

Unlock Scores for Free

Analyst opinions

9 Analysts have issued a Omnicell, Inc. forecast:

4x Buy
44%
4x Hold
44%
1x Sell
11%

Analyst opinions

9 Analysts have issued a Omnicell, Inc. forecast:

Buy
44%
Hold
44%
Sell
11%

Financial data from Omnicell, Inc.

Mar '24
+/-
%
Net profit -16 -16
5% 5%
-6%
Depreciation and amortization 23 23
4% 4%
9%
Share compensation 8.64 8.64
38% 38%
4%
Operating cash flow 50 50
223% 223%
20%
Investments 12 12
10% 10%
5%
Dividend paid - -
-
-
Free cash flow 41 41
672% 672%
17%

Figures in millions USD.

Don't miss a thing! We will send you all news about the Omnicell, Inc. share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Omnicell, Inc. Share News

Neutral
Business Wire
about 2 months ago
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation.
Neutral
Business Wire
2 months ago
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the BofA Securities 2024 Health Care Conference.
Neutral
Seeking Alpha
2 months ago
Omnicell, Inc. (NASDAQ:OMCL ) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Kathleen Nemeth – Senior Vice President-Investor Relations Randall Lipps – Founder, Chairman, President and Chief Executive Officer Nchacha Etta – Executive Vice President and Chief Financial Officer Conference Call Participants Stan Berenshteyn – Wells Fargo Matt Hewitt – Craig-Hallum Sco...
More Omnicell, Inc. News

Company profile

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence; platform and interoperability; central pharmacy dispensing; medication adherence; population health; and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.

Head office United States
CEO Randall Lipps
Employees 3,650
Founded 1992
Website www.omnicell.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today